Please use this identifier to cite or link to this item: https://repositorio.unifesp.br/handle/11600/34973
Title: New mutations in the GLA gene in Brazilian families with Fabry disease
Authors: Turaca, Lauro Thiago [UNIFESP]
Pessoa, Juliana Gilbert [UNIFESP]
Motta, Fabiana Louise [UNIFESP]
Munoz Rojas, Maria Veronica
Mueller, Karen Barbosa [UNIFESP]
Lourenco, Charles Marques
Marques, Wilson Junior
D'Almeida, Vania [UNIFESP]
Martins, Ana Maria [UNIFESP]
Pesquero, Joao Bosco [UNIFESP]
Universidade Federal de São Paulo (UNIFESP)
Genzyme Brasil
Universidade de São Paulo (USP)
Keywords: alpha-galactosidase A
fabry disease
Brazilian families
GLA gene
lysosomal storage disease
mutation analysis
Issue Date: 1-Jun-2012
Publisher: Nature Publishing Group
Citation: Journal of Human Genetics. New York: Nature Publishing Group, v. 57, n. 6, p. 347-351, 2012.
Abstract: Fabry disease (FD) is an X-linked inborn error of glycosphingolipid catabolism that results from mutations in the alpha-galactosidase A (GLA) gene. Evaluating the enzymatic activity in male individuals usually performs the diagnosis of the disease, but in female carriers the diagnosis based only on enzyme assays is often inconclusive. in this work, we analyzed 568 individuals from 102 families with suspect of FD. Overall, 51 families presented 38 alterations in the GLA gene, among which 19 were not previously reported in literature. the alterations included 17 missense mutations, 7 nonsense mutations, 7 deletions, 6 insertions and 1 in the splice site. Six alterations (R112C, R118C, R220X, R227X, R342Q and R356W) occurred at CpG dinucleotides. Five mutations not previously described in the literature (A156D, K237X, A292V, I317S, c.1177_1178insG) were correlated with low GLA enzyme activity and with prediction of molecular damages. From the 13 deletions and insertions, 7 occurred in exons 6 or 7 (54%) and 11 led to the formation of a stop codon. the present study highlights the detection of new genomic alterations in the GLA gene in the Brazilian population, facilitating the selection of patients for recombinant enzyme-replacement trials and offering the possibility to perform prenatal diagnosis. Journal of Human Genetics (2012) 57, 347-351; doi:10.1038/jhg.2012.32; published online 3 May 2012
URI: http://repositorio.unifesp.br/handle/11600/34973
ISSN: 1434-5161
Other Identifiers: http://dx.doi.org/10.1038/jhg.2012.32
Appears in Collections:Em verificação - Geral

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.